CVX vs MSFT: Which Is the Better Buy?

Side-by-side comparison of Chevron Corporation and Microsoft Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Chevron Corporation Β· Energy
$205.52
+35.9% upside to fair value
Med Conviction Grade B High Quality
VS
Microsoft Corporation Β· Technology
$497.12
+41.3% upside to fair value
High Conviction Grade A High Quality
QuantHub Verdict
MSFT has more upside to fair value (+41.3%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CVX MSFT
Current Price $205.52 $497.12
Fair Value Estimate $279.29 $702.35
Upside to Fair Value +35.9% +41.3%
Market Cap $409.3B $3,691.4B
Forward P/E β€” β€”
EV / EBITDA 7.8x 18.3x
Price / Sales 2.0x 11.1x
Price / FCF 15.0x 55.1x
Revenue Growth YoY +51.4% +17.7%
Gross Margin 31.0% 67.9%
Operating Margin 15.8% 46.8%
Return on Equity 11.0% 33.2%
Dividend Yield 3.43% 0.73%
FCF Yield 6.67% 1.81%
Analyst Consensus Buy Strong Buy
Investment Thesis
CVX β€” Chevron Corporation
Chevron is a global integrated oil and gas major organized into Upstream and Downstream segments, spanning crude oil and natural gas exploration, LNG processing and transport, refining, petrochemicals, and lubricants, with 43,039 full-time employees and a market capitalization of $409.31 billion at a current price of $205.52. The business quality is high: it generates $13.71 of free cash flow per…
MSFT β€” Microsoft Corporation
Microsoft is a global infrastructure-software platform spanning Azure, Microsoft 365, security, Dynamics, Windows, GitHub and AI copilots, with high business quality supported by enterprise distribution, explicitly cited switching costs, a $678 billion commercial RPO balance, 67.9% TTM gross margin, 46.8% TTM operating margin, 40.3% TTM net margin and 33.2% ROE. Revenue grew 17.7% and earnings gr…
Accumulation Zones
Metric CVX MSFT
Zone Low $209.47 $526.76
Zone High $237.40 $597.00
In Buy Zone? Yes Yes
← CVX Research    MSFT Research β†’    All Research